1177757

Leslie Kersun, M.D. — FEI 3023470088

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 10, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)